Royal Bank of Canada’s Immunocore IMCR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.46M | Buy |
46,566
+2,555
| +6% | +$80.2K | ﹤0.01% | 3272 |
|
|
2025
Q1 | $1.31M | Buy |
44,011
+13,689
| +45% | +$406K | ﹤0.01% | 2964 |
|
|
2024
Q4 | $895K | Sell |
30,322
-14,648
| -33% | -$432K | ﹤0.01% | 3225 |
|
|
2024
Q3 | $1.4M | Buy |
44,970
+515
| +1% | +$16K | ﹤0.01% | 2904 |
|
|
2024
Q2 | $1.51M | Buy |
44,455
+2,158
| +5% | +$73.2K | ﹤0.01% | 2812 |
|
|
2024
Q1 | $2.75M | Buy |
42,297
+73
| +0.2% | +$4.74K | ﹤0.01% | 2369 |
|
|
2023
Q4 | $2.88M | Buy |
42,224
+8,967
| +27% | +$612K | ﹤0.01% | 2345 |
|
|
2023
Q3 | $1.73M | Buy |
33,257
+9,521
| +40% | +$494K | ﹤0.01% | 2586 |
|
|
2023
Q2 | $1.42M | Buy |
23,736
+23,705
| +76,468% | +$1.42M | ﹤0.01% | 2747 |
|
|
2023
Q1 | $2K | Buy |
31
+22
| +244% | +$1.42K | ﹤0.01% | 6382 |
|
|
2022
Q4 | $1K | Sell |
9
-249
| -97% | -$27.7K | ﹤0.01% | 6564 |
|
|
2022
Q3 | $12K | Sell |
258
-2,400
| -90% | -$112K | ﹤0.01% | 5858 |
|
|
2022
Q2 | $99K | Hold |
2,658
| – | – | ﹤0.01% | 4878 |
|
|
2022
Q1 | $79K | Buy |
+2,658
| New | +$79K | ﹤0.01% | 5328 |
|